Dr. Rogers’ grant from the National Institute of General Medicine Sciences (part of the National Institutes of Health) builds upon data from her recently published study in Nucleic Acids Research on ...
Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...
ARLINGTON, Texas — A UT-Arlington biologist is leading a $1.8 million federally funded project to study the molecular processes affecting gene regulation to better understand how small genetic ...
Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
New Phytologist is a leading world journal, publishing original research papers on all aspects of the plant sciences. It publishes also a prestigious series of invited reviews, Tansley Reviews, named ...
With the question of immunotherapeutics’ efficacy answered in the resounding affirmative, the challenge has shifted to the practical considerations of how to cost-effectively manufacture these highly ...
A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests ...
Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA highlighting the role of exosomal RNA (exRNA) in head and neck cancers (HNCs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback